Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-044219
Filing Date
2013-09-13
Accepted
2013-09-13 18:19:47
Documents
1
Period of Report
2013-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11162
  Complete submission text file 0001209191-13-044219.txt   12545
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Issuer) CIK: 0001356857 (see all company filings)

EIN.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
THOMPSON JOHN CRAIG (Reporting) CIK: 0001509643 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34828 | Film No.: 131097260